Article Details

Connect Biopharma Announces First Patient Dosed in China Pivotal Trial Evaluating CBP ...

Retrieved on: 2021-09-02 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Connect Biopharma Announces First Patient Dosed in China Pivotal Trial Evaluating CBP .... View article details on hiswai:

Excerpt

02, 2021 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ... a global clinical-stage biopharmaceutical company dedicated to improving ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up